image
C4 Therapeutics, Inc. CCCC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 4.31
-8.69 %
$ 304 M
Market Cap
-2.52
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -33.25% -4.74% -7.33%
Annual Report FY 10-K 2022-12-31 -32.08% -47.03% -57.71%
Annual Report FY 10-K 2021-12-31 37.93% -29.70% -35.87%
Annual Report FY 10-K 2020-12-31 55.25% -94.54% -70.51%
Annual Report FY 10-K 2019-12-31 10.42% -117.04% -116.32%
Annual Report FY 10-K 2018-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-09-30 38.75% 8.77% -1.57%
Quarterly Report Q1 8-K 2024-06-30 350.68% 50.68% 42.92%
Quarterly Report Q4 8-K 2024-03-31 -19.15% 16.43% 11.07%
Quarterly Report Q3 8-K 2023-12-31 14.26% 3.67% 2.26%
Quarterly Report Q2 8-K 2023-09-30 63.93% 13.97% 14.41%
Quarterly Report Q1 8-K 2023-06-30 -80.74% -30.91% -37.19%
Quarterly Report Q4 8-K 2023-03-31 -50.89% -6.49% -15.49%
Quarterly Report Q3 8-K 2022-12-31 -85.79% -130.41% -151.02%
Quarterly Report Q2 8-K 2022-09-30 -20.54% -27.33% -33.95%
Quarterly Report Q1 8-K 2022-06-30 41.44% -21.52% -23.82%
Quarterly Report Q4 8-K 2022-03-31 3.07% -51.98% -52.95%
Quarterly Report Q3 8-K 2021-12-31 143.02% 28.16% 19.30%
Quarterly Report Q2 8-K 2021-09-30 0.63% -13.04% -32.18%
Quarterly Report Q1 8-K 2021-06-30 1.15% -109.21% -103.67%
Quarterly Report Q4 8-K 2021-03-31 8.95% -76.05% -66.23%
Quarterly Report Q3 8-K 2020-12-31 0.65% -117.45% -80.05%
Quarterly Report Q2 8-K 2020-09-30 57.48% -116.32% -83.47%
Quarterly Report Q1 8-K 2020-06-30 147.73% -18.73% -45.24%
Quarterly Report Q4 8-K 2020-03-31 74.61% -31.04% -65.02%
Quarterly Report Q3 8-K 2019-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2019-09-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-06-30 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2019-03-31 0.00% 0.00% 0.00%